AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 050 GBX
-0.87%
Market Closed
Updated:
May 6, 2024
AstraZeneca PLC
Depreciation & Amortization
|
AstraZeneca PLC
Depreciation & Amortization Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Depreciation & Amortization
-$3.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Depreciation & Amortization
-£72m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
3%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Depreciation & Amortization
-$13m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Depreciation & Amortization
-$88m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Depreciation & Amortization
-£140.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is AstraZeneca PLC's Depreciation & Amortization?
Depreciation & Amortization
-3.9B
USD
-3.9B
USD
Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Depreciation & Amortization amounts to -3.9B USD.
What is AstraZeneca PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-15%
-15%
Over the last year, the Depreciation & Amortization growth was 6%. The average annual Depreciation & Amortization growth rates for AstraZeneca PLC have been -27% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
